Novel antibodies against IGF-IR

Details for Australian Patent Application No. 2008214647 (hide)

Owner Glaxo Group Limited

Inventors Burden, Michael Neil; Ellis, Jonathan Henry; Hamblin, Paul Andrew; Shah, Radha; Lewis, Alan Peter

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008214647

PCT Pub. Number WO2008/098917

Priority 60/953,210 01.08.07 US; 0702888.9 14.02.07 GB

Filing date 12 February 2008

Wipo publication date 21 August 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/098917 Priority application(s): WO2008/098917

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214658-Method of inducing virus tolerance of plants

2008214639-Prevention and treatment of sub-clinical PCVD